Ushijima C, Tsukamoto S, Yamazaki K, Yoshino I, Sugio K, Sugimachi K
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Lung Cancer. 2001 Nov;34(2):233-41. doi: 10.1016/s0169-5002(01)00246-x.
We attempted to determine if the degree of angiogenesis can serve as a prognostic factor in the case of completely resected non-small cell lung cancer patients, with special reference to the center and the periphery of the tumor tissue.
For 255 Japanese patients who underwent completely resected non-small cell lung cancer (NSCLC), micro vessel density (MVD) was assessed by visual quantification of microvessels immunostained with anti-CD34 monoclonal antibody in 5 m section. Vascular endothelial growth factor (VEGF) was also immunostained on the same paraffin block specimen.
MVD at the center (MVD-c) and that at the periphery (MVD-p) were frequently different in each individual although a weak positive correlation was observed (r=0.499, P<0.0001). One hundred and one patients with high MVD-p, but not the 107 patients with high MVD-c, showed a significantly higher proportion of advanced stage, larger tumor size and nodal metastasis as compared with MVD. The 5 year survival rate and median survival time for the high MVD-p group were significantly lower than that of low the MVD-p group (43.0%/31 months vs 48.6%/54 months, P=0.0256). As to the relationship among vascular endothelial growth factor (VEGF) and MVD, expression of VEGF was not associated with the degree of MVD. However, patients with high grade MVD-p showed an unfavorable prognosis in cases of high expression of VEGF.
High MVD-p is associated with advancement of NSCLC, and it was particularly apparent in conjunction with high VEGF expression.
我们试图确定血管生成程度是否可作为完全切除的非小细胞肺癌患者的预后因素,特别参考肿瘤组织的中心和周边区域。
对于255例接受完全切除的非小细胞肺癌(NSCLC)的日本患者,通过对用抗CD34单克隆抗体免疫染色的微血管在5μm切片中进行视觉定量来评估微血管密度(MVD)。血管内皮生长因子(VEGF)也在同一块石蜡包埋标本上进行免疫染色。
尽管观察到中心部位的MVD(MVD-c)和周边部位的MVD(MVD-p)之间存在弱正相关(r = 0.499,P < 0.0001),但每个个体中二者常常不同。与MVD相比,101例MVD-p高的患者,而非107例MVD-c高的患者,显示出晚期、肿瘤尺寸较大和淋巴结转移的比例显著更高。MVD-p高的组的5年生存率和中位生存时间显著低于MVD-p低的组(43.0%/31个月对48.6%/54个月,P = 0.0256)。至于血管内皮生长因子(VEGF)与MVD之间的关系,VEGF的表达与MVD程度无关。然而,在VEGF高表达的情况下,MVD-p高的患者预后不良。
高MVD-p与NSCLC的进展相关,并且在与高VEGF表达同时出现时尤为明显。